Primary immunodeficiencies and the rheumatologist

被引：3

作者：

O'Shea, JJ ^{[1
]}

Holland, S ^{[1
]}

Candotti, F ^{[1
]}

机构：

[1] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD USA

来源：

CURRENT OPINION IN RHEUMATOLOGY | 2003年 / 15卷 / 04期

关键词：

D O I：

10.1097/00002281-200307000-00007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：413 / 416

页数：4

共 8 条

[1]

CALABRESE LH, 1998, RHEUMATOLOGY

[2] Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways [J].

Candotti, F ;

Notarangelo, L ;

Visconti, R ;

O'Shea, J .

JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (10) :1261-1269

[3] Primary immunodeficiency diseases: an experimental model for molecular medicine [J].

Fischer, A .

LANCET, 2001, 357 (9271) :1863-1869

[4] The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations [J].

Hull, KM ;

Shoham, N ;

Chae, JJ ;

Aksentijevich, I ;

Kastner, DL .

CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (01) :61-69

[5] Cytokines and autoimmunity [J].

O'Shea, JJ ;

Ma, A ;

Lipsky, P .

NATURE REVIEWS IMMUNOLOGY, 2002, 2 (01) :37-45

[6]

Pickering M C, 2000, Adv Immunol, V76, P227

[7]

ROSEN FS, 1987, CIBA F SYMP, V129, P135

[8] Control of T-cell activation by CD4+ CD25+ suppressor T cells [J].

Shevach, EM ;

McHugh, RS ;

Piccirillo, CA ;

Thornton, AM .

IMMUNOLOGICAL REVIEWS, 2001, 182 :58-67

← 1 →